- Home
- FGL vs CGTX Comparison
FGL vs CGTX Comparison
Compare FGL & CGTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FGL
- CGTX
- Stock Information
- Founded
- FGL 2021
- CGTX 2007
- Country
- FGL Malaysia
- CGTX United States
- Employees
- FGL N/A
- CGTX N/A
- Industry
- FGL
- CGTX Biotechnology: Pharmaceutical Preparations
- Sector
- FGL
- CGTX Health Care
- Exchange
- FGL NYSE
- CGTX Nasdaq
- Market Cap
- FGL 25.4M
- CGTX 20.5M
- IPO Year
- FGL 2024
- CGTX 2021
- Fundamental
- Price
- FGL $0.73
- CGTX $0.32
- Analyst Decision
- FGL
- CGTX Strong Buy
- Analyst Count
- FGL 0
- CGTX 5
- Target Price
- FGL N/A
- CGTX $5.63
- AVG Volume (30 Days)
- FGL 1.2M
- CGTX 1.9M
- Earning Date
- FGL 07-07-2025
- CGTX 08-07-2025
- Dividend Yield
- FGL N/A
- CGTX N/A
- EPS Growth
- FGL N/A
- CGTX N/A
- EPS
- FGL N/A
- CGTX N/A
- Revenue
- FGL $20,205,441.00
- CGTX N/A
- Revenue This Year
- FGL N/A
- CGTX N/A
- Revenue Next Year
- FGL N/A
- CGTX N/A
- P/E Ratio
- FGL N/A
- CGTX N/A
- Revenue Growth
- FGL N/A
- CGTX N/A
- 52 Week Low
- FGL $0.66
- CGTX $0.22
- 52 Week High
- FGL $5.26
- CGTX $2.54
- Technical
- Relative Strength Index (RSI)
- FGL N/A
- CGTX 54.36
- Support Level
- FGL N/A
- CGTX $0.25
- Resistance Level
- FGL N/A
- CGTX $0.33
- Average True Range (ATR)
- FGL 0.00
- CGTX 0.03
- MACD
- FGL 0.00
- CGTX 0.00
- Stochastic Oscillator
- FGL 0.00
- CGTX 91.98
About FGL FOUNDER GROUP LTD
Founder Group Ltd is a solar solutions provider in Malaysia, offering end-to-end services for commercial and industrial sectors, as well as large-scale solar power projects, encompassing project design, engineering, and comprehensive project management. Its focus is on two key segments: large-scale solar projects and commercial and industrial (C&I) solar projects. Large-scale solar projects are utility scale solar PV power plants with installed generating capacity of 1 MWac or more. C&I projects are smaller scale solar projects where the solar PV systems are installed on rooftops and are designed to generate electricity for commercial and industrial properties for their own consumption, such as factories, warehouses and commercial stores. Its revenue is derived from Malaysia.
About CGTX Cognition Therapeutics Inc.
Cognition Therapeutics Inc is a clinical-stage biopharmaceutical company engaged in the discovery and development of, small-molecule therapeutics targeting age-related degenerative diseases and disorders of the central nervous system and retina. Its product candidate CT1812, is an orally delivered, small-molecule antagonist designed to penetrate the blood-brain barrier and bind selectively to the S2R complex.